Tetsunari Oyama
- Molecular Biology top 2%
- Oncology top 0.5%
- Cancer Research top 0.5%
- Surgery top 2%
- Pulmonary and Respiratory Medicine top 2%
- Co-authors
- Takaaki SanoTakashi NakajimaKyoichi KairaJun HoriguchiKenji KashiwabaraYoshikatsu KanaiToshio FukudaIzumi Takeyoshi
- Topics
- Breast Cancer Treatment Studies (37 papers)Breast Lesions and Carcinomas (29 papers)Epigenetics and DNA Methylation (29 papers)
- Cited by
- BiochemistryCancer ResearchOncology
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Tetsunari Oyama
269 papers receiving 7.1k citations
Peers
Comparison fields: 5 of 124
- Molecular Biology 2.9k
- Oncology 2.8k
- Cancer Research 1.7k
- Surgery 1.3k
- Pulmonary and Respiratory Medicine 1.0k
Countries citing papers authored by Tetsunari Oyama
This map shows the geographic impact of Tetsunari Oyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsunari Oyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsunari Oyama more than expected).
Fields of papers citing papers by Tetsunari Oyama
This network shows the impact of papers produced by Tetsunari Oyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsunari Oyama. The network helps show where Tetsunari Oyama may publish in the future.
Co-authorship network of co-authors of Tetsunari Oyama
This figure shows the co-authorship network connecting the top 25 collaborators of Tetsunari Oyama. A scholar is included among the top collaborators of Tetsunari Oyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsunari Oyama. Tetsunari Oyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 3 | |
| 4 | 7 | |
| 5 | 3 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 5 | |
| 9 | 4 | |
| 10 | 10 | |
| 11 | 4 | |
| 12 | 7 | |
| 13 | 10 | |
| 14 | 15 | |
| 15 | 25 | |
| 16 | 52 | |
| 17 | Pathological complete response and prognosis in patients receiving neoadjuvant paclitaxel and trastuzumab with and without anthracyclines for stage II and III, HER2-positive operable breast cancer: a single-institute experience. | 7 |
| 18 | 24 | |
| 19 | Neoadjuvant weekly paclitaxel with and without trastuzumab in locally advanced or metastatic breast cancer. | 14 |
| 20 | 2 |
About Tetsunari Oyama
Tetsunari Oyama is a scholar working on Oncology, Biochemistry and Cancer Research, having authored 281 papers that have together received 7.2k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (37 papers), Breast Lesions and Carcinomas (29 papers) and Epigenetics and DNA Methylation (29 papers). The work is most often cited by research in Biochemistry (865 citations), Cancer Research (1.7k citations) and Oncology (2.8k citations). Tetsunari Oyama has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Takaaki Sano, Takashi Nakajima, Kyoichi Kaira, Jun Horiguchi, Kenji Kashiwabara, Yoshikatsu Kanai, Toshio Fukuda, Izumi Takeyoshi, Shushi Nagamori and Kazuaki Chikamatsu. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.